NGS performed on a tumor sample from the liver biopsy obtained at the time of diagnosis revealed CDKN2A mutation A102P, ARID1A mutation I1485fs*5, CCND1 amplification, FGF19 amplification, FGF3 amplification and FGF4 amplification (Figure 1). This evidence concerns the gene ARID1A and neoplasm.